-

Topical Absorbable Hemostats: Medical Devices Pipeline Assessment, 2019 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Topical Absorbable Hemostats pipeline products.

Scope

  • Extensive coverage of the Topical Absorbable Hemostats under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Topical Absorbable Hemostats and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Topical Absorbable Hemostats under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Introduction

1.1 Topical Absorbable Hemostats Overview

2 Products under Development

2.1 Topical Absorbable Hemostats - Pipeline Products by Stage of Development

2.2 Topical Absorbable Hemostats - Pipeline Products by Segment

2.3 Topical Absorbable Hemostats - Pipeline Products by Territory

2.4 Topical Absorbable Hemostats - Pipeline Products by Regulatory Path

2.5 Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date

2.6 Topical Absorbable Hemostats - Ongoing Clinical Trials

3 Topical Absorbable Hemostats - Pipeline Products under Development by Companies

3.1 Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development

3.2 Topical Absorbable Hemostats - Pipeline Products by Stage of Development

4 Topical Absorbable Hemostats Companies and Product Overview

4.1 3-D Matrix Ltd Company Overview

4.2 Angiotech Pharmaceuticals Inc Company Overview

4.3 Anika Therapeutics Inc Company Overview

4.4 APRUS Bio-Medical Innovations Pvt Ltd Company Overview

4.5 Arch Therapeutics Inc Company Overview

4.6 Baxter Healthcare Corp Company Overview

4.7 Baxter International Inc Company Overview

4.8 Beth Israel Deaconess Medical Center Inc Company Overview

4.9 Biomedica Management Corp Company Overview

4.10 Biom'Up SAS Company Overview

4.11 C. R. Bard Inc Company Overview

4.12 Cellphire Inc Company Overview

4.13 Ceramicos Para Aplicacoes Medicas SA Company Overview

4.14 Columbia University Company Overview

4.15 Covalent Medical, Inc. (Inactive) Company Overview

4.16 Covalon Technologies Ltd Company Overview

4.17 Cresilon Inc Company Overview

4.18 CryoLife Inc Company Overview

4.19 Endomedix Incorporated Company Overview

4.20 Entegrion Inc Company Overview

4.21 Ethicon US LLC Company Overview

4.22 ETX Pharma Inc Company Overview

4.23 Gamma Therapeutics Inc Company Overview

4.24 GATT Technologies BV Company Overview

4.25 gel-e Inc Company Overview

4.26 Haemostatix Ltd Company Overview

4.27 Hemostasis LLC Company Overview

4.28 HLL Lifecare Ltd Company Overview

4.29 Keratin Biosciences Inc Company Overview

4.30 Leader Biomedical Europe BV Company Overview

4.31 LifeBond Ltd Company Overview

4.32 Protege Biomedical Company Overview

4.33 Resorba GmbH Company Overview

4.34 Rice University Company Overview

4.35 Sanara MedTech Inc Company Overview

4.36 Sanofi Biosurgery Inc Company Overview

4.37 Sea Run Holdings Inc Company Overview

4.38 St Teresa Medical Inc Company Overview

4.39 Tectum Company Overview

4.40 The Medicines Company Company Overview

4.41 Therus Corporation Company Overview

4.42 Thrombotargets Corp Company Overview

4.43 United Health Products, Inc. Company Overview

4.44 University of Grenoble Alpes Company Overview

4.45 Virginia Commonwealth University Company Overview

4.46 Xcede Technologies Inc Company Overview

5 Topical Absorbable Hemostats- Recent Developments

5.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019

5.2 Nov 12, 2019: Cook Medical's leadership updates in Asia-pacific reinforce focus on growth and physician relationships

5.3 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn

5.4 Oct 31, 2019: gel-e announces breakthrough status designation from the U.S. Food and Drug Administration (FDA) for its first internal-use flowable device

5.5 Oct 31, 2019: Sanofi Q3 well on track

5.6 Oct 30, 2019: The Medicines Company reports third-quarter 2019 financial results and achievement of major milestones for inclisiran

5.7 Oct 30, 2019: CryoLife reports third quarter 2019 financial results

5.8 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019

5.9 Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results

5.10 Oct 24, 2019: Anika reports third quarter 2019 financial results

Companies Mentioned

  • Teleflex Inc
  • Smiths Medical
  • Medtronic Plc
  • Dragerwerk AG & Co KGaA
  • GE Healthcare LLC
  • ResMed Inc
  • Ambu A/S
  • Koninklijke Philips NV
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd
  • Compumedics Ltd
  • Masimo Corp
  • Fisher & Paykel Healthcare Corporation Ltd
  • Philips Respironics Inc
  • Nihon Kohden Corp
  • Medline Industries Inc
  • GIMA, SpA
  • Nonin Medical Inc
  • Becton Dickinson and Co
  • Natus Medical Incorporated
  • B. Braun Melsungen AG
  • Spacelabs Healthcare Inc
  • Vyaire Medical Inc
  • Maquet AG
  • HEYER Medical AG
  • Hamilton Medical AG

For more information about this report visit https://www.researchandmarkets.com/r/z4ugx2

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom